{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T13:51:45Z","timestamp":1724421105639},"reference-count":19,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1248\/bpb.b18-00392","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T18:40:06Z","timestamp":1541011206000},"page":"1727-1731","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Magnesium Oxide on the Serum Duloxetine Concentration and Antidepressant-Like Effects of Duloxetine in Rats"],"prefix":"10.1248","volume":"41","author":[{"given":"Satoru","family":"Esumi","sequence":"first","affiliation":[{"name":"Department of Hospital Pharmacy, Okayama University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Kitamura","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Okayama University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Yokota-Kumasaki","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Okayama University Medical School"},{"name":"Department of Pharmacy, Osaka General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"Ushio","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Okayama University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akane","family":"Yamada-Takemoto","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Okayama University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Okayama University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Okayama University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Okayama University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Sendo","sequence":"additional","affiliation":[{"name":"Department of Hospital Pharmacy, Okayama University Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. <i>Eur. Psychiatry<\/i>, <b>21<\/b>, 367\u2013378 (2006).","DOI":"10.1016\/j.eurpsy.2006.03.004"},{"key":"2","unstructured":"2) Bailey RK, Mallinckrodt CH, Wohlreich MM, Watkin JG, Plewes JM. Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy. <i>J. Natl. Med. Assoc.<\/i>, <b>98<\/b>, 437\u2013447 (2006)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ishihara M, Ikesue H, Matsunaga H, Suemaru K, Kitaichi K, Suetsugu K, Oishi R, Sendo T, Araki H, Itoh Y, Japanese Study Group for the Relief of Opioid-induced Gastrointestinal Dysfunction. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction. <i>Clin. J. Pain<\/i>, <b>28<\/b>, 373\u2013381 (2012).","DOI":"10.1097\/AJP.0b013e318237d626"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Yamasaki M, Funakoshi S, Matsuda S, Imazu T, Takeda Y, Murakami T, Maeda Y. Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy. <i>Eur. J. Clin. Pharmacol.<\/i>, <b>70<\/b>, 921\u2013924 (2014).","DOI":"10.1007\/s00228-014-1694-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) McBain J, Dunn RC. Sorption from solution by active magnesium oxide. <i>J. Colloid Sci.<\/i>, <b>3<\/b>, 303\u2013311 (1948).","DOI":"10.1016\/0095-8522(48)90017-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Nga NK, Hong PT, Lam TD, Huy TQ. A facile synthesis of nanostructured magnesium oxide particles for enhanced adsorption performance in reactive blue 19 removal. <i>J. Colloid Interface Sci.<\/i>, <b>398<\/b>, 210\u2013216 (2013).","DOI":"10.1016\/j.jcis.2013.02.018"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Bighley LD, Spivey RJ. Chelates of dicumarol I: Preparation and structure identification of magnesium chelate. <i>J. Pharm. Sci.<\/i>, <b>66<\/b>, 1124\u20131127 (1977).","DOI":"10.1002\/jps.2600660818"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Neuvonen PJ, Kivisto KT, Lehto P. Interference of dairy products with the absorption of ciprofloxacin. <i>Clin. Pharmacol. Ther.<\/i>, <b>50<\/b>, 498\u2013502 (1991).","DOI":"10.1038\/clpt.1991.174"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nix DE, Watson WA, Lener ME, Frost RW, Krol G, Goldstein H, Lettieri J, Schentag JJ. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin. <i>Clin. Pharmacol. Ther.<\/i>, <b>46<\/b>, 700\u2013705 (1989).","DOI":"10.1038\/clpt.1989.207"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kawaura A, Kitamura Y, Tanida N, Akiyama J, Mizutani M, Harada K, Morishita M, Inoue S, Kano Y, Okano T, Takeda E. Antidepressant-like effect of 1\u03b1-hydroxyvitamin D<sub>3<\/sub> on mice in the forced swimming test. <i>J. Nutr. Sci. Vitaminol.<\/i>, <b>63<\/b>, 81\u201384 (2017).","DOI":"10.3177\/jnsv.63.81"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kitamura Y, Yagi T, Kitagawa K, Shinomiya K, Kawasaki H, Asanuma M, Gomita Y. Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats. <i>Naunyn Schmiedebergs Arch. Pharmacol.<\/i>, <b>382<\/b>, 151\u2013158 (2010).","DOI":"10.1007\/s00210-010-0521-x"},{"key":"12","unstructured":"12) Firoz M, Graber M. Bioavailability of U.S. commercial magnesium preparations. <i>Magnes. Res.<\/i>, <b>14<\/b>, 257\u2013262 (2001)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Horibata K, Tanoue A, Ito M, Takemura Y. Relationship between renal function and serum magnesium concentration in elderly outpatients treated with magnesium oxide. <i>Geriatr. Gerontol. Int.<\/i>, <b>16<\/b>, 600\u2013605 (2016).","DOI":"10.1111\/ggi.12530"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Andersen J, Christensen H, Pachler JH, Hallin M, Thaysen HV, Kehlet H. Effect of the laxative magnesium oxide on gastrointestinal functional recovery in fast-track colonic resection: a double-blind, placebo-controlled randomized study. <i>Colorectal Dis.<\/i>, <b>14<\/b>, 776\u2013782 (2012).","DOI":"10.1111\/j.1463-1318.2011.02796.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ciulla L, Menezes HS, Bueno BB, Schuh A, Alves RJ, Abegg MP. Antidepressant behavioral effects of duloxetine and fluoxetine in the rat forced swimming test. <i>Acta Cir. Bras.<\/i>, <b>22<\/b>, 351\u2013354 (2007).","DOI":"10.1590\/S0102-86502007000500005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Menezes HS, Bueno BB, Ciulla L, Schuh A, Luz Fde F, Alves RJ, Abegg MP, Cirino SL. Antidepressant behavioral effects of duloxetine and amitriptyline in the rat forced swimming test. <i>Acta Cir. Bras.<\/i>, <b>23<\/b>, 447\u2013450 (2008).","DOI":"10.1590\/S0102-86502008000500010"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Abanades S, van der Aart J, Barletta JA, Marzano C, Searle GE, Salinas CA, Ahmad JJ, Reiley RR, Pampols-Maso S, Zamuner S, Cunningham VJ, Rabiner EA, Laruelle MA, Gunn RN. Prediction of repeat-dose occupancy from single-dose data: characterisation of the relationship between plasma pharmacokinetics and brain target occupancy. <i>J. Cereb. Blood Flow Metab.<\/i>, <b>31<\/b>, 944\u2013952 (2011).","DOI":"10.1038\/jcbfm.2010.175"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kumar R, Gokulakrishnan N, Kumar R, Krishna VM, Saravanan A, Supriya S, Somanathan T. Can be a bimetal oxide ZnO\u2013MgO nanoparticles anticancer drug carrier and deliver? Doxorubicin adsorption\/release study. <i>J. Nanosci. Nanotechnol.<\/i>, <b>15<\/b>, 1543\u20131553 (2015).","DOI":"10.1166\/jnn.2015.8915"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Waldschmitt C, Vogel F, Pfuhlmann B, Hiemke C. Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey. <i>Pharmacopsychiatry<\/i>, <b>42<\/b>, 189\u2013193 (2009).","DOI":"10.1055\/s-0029-1220890"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/11\/41_b18-00392\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T00:38:20Z","timestamp":1541205500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/11\/41_b18-00392\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00392","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}